EUROPEAN COOPERATION IN SCIENCE AND TECHNOLOGY Dr. Inga
Dadeshidze Science Officer COST Administration
[email protected] Sent by e-mail for BM1309 MC / WG Meeting
2-3/10/2014, Split, Croatia Sincere apologies for not being able to
attend Wish you very fruitful and successful Meeting
Slide 2
COST POLICIES H2020 2
Slide 3
COST Policies under H2020 Inclusiveness Early stage
researchers, ESRs Gender balance International cooperation
SMEs/industry participation 3 COST has identified its priorities
and developed its policies on:
Slide 4
COST Inclusiveness Policy 4 Originated from: Political context
of Horizon 2020. Geographical context of the COST Member Countries.
With the aim to: Encourage and enable researchers from less
research- intensive countries across the COST Member Countries to
set up and/or join COST Actions and get more intensively involved
in all COST activities. Counterbalancing research communities
unequal access to knowledge infrastructures, funding and resources
distribution.
Slide 5
COST Inclusiveness countries 5
Slide 6
Leadership roles at Action level. Locating Action meetings,
workshops & conferences. Promoting STSMs tool in these
countries. Benefiting from COST networking tools. Strategy of the
Action in order to attract top-scientist from target countries. 6
IMPLEMENTATION at MC Level: Inclusiveness SOME EXAMPLES: The ACTION
should have a plan towards inclusiveness that should be revised an
updated at every MC meeting.
Slide 7
Set a target figure, from which a percentage of the Action
budget shall be used for ESRs-STSMs. Special STSMs for Early Stage
Researchers: up to 6 months with a grant of up to 3.500 EUR.
Specific Support for Training Schools. An early stage researchers'
network may be created within the Action as a think tank.
Leadership roles at Action level (WG leaders). 7 IMPLEMENTATION at
MC Level: SOME EXAMPLES: Early Stage Researchers (PhD + max. 8
years) The ACTION should have a plan for the involvement of ESR
that should be revised and updated at every MC meeting.
Slide 8
Gender balance With the aim to: Encourage and enable under
represented gender to be intensively involved in all COST
activities. Networking the way to gender equality in science and
technology. 8 IMPLEMENTATION at MC Level: SOME EXAMPLES: Leadership
roles at Action level (WG leaders) Gender balance in allocation of
STSMs Active promotion of STSMs to ESRs of under-represented gender
Gender balance in allocation of Training School Trainee grants
Gender balance in allocation of meeting reimbursement places
Slide 9
International Cooperation With the aim to: to support the
involvement of researchers from Near Neighbour and International
Partner countries in COST Actions on the basis of mutual benefit. 9
IMPLEMENTATION at Action Level: SOME EXAMPLES: Approved IPC and NNC
institutions can host STSMs Researcher from Approved NNC
institutions can: Apply for STSM Attend Training Schools
Researchers from Approved IPC and NNC institutions can be trainers
COST 4115/13: COST International Cooperation Rules
http://www.cost.eu/about_cost/cost_countries/international_cooperation
Slide 10
Facilitate/ encourage industry/ stakeholder participation eg
programme has a half/ full day focussed just on industry-relevant
issues 10 SMEs & Industry
Slide 11
COST Would you like to participate in COST Action or in other
COST activities? 11
COST NATIONAL COORDINATOR
http://www.cost.eu/about_cost/who/%28type%29/3 Science Officer
ACTION CHAIR 15 http://www.cost.eu/participate/join_action Dr Inga
Dadshidze, SO [email protected] Dr Mafalda Quintas, SO TD
[email protected] Dr Giuseppe Lugano, SO TD
[email protected]
Slide 16
Domain BMBS 16 Biomedicine and Molecular Biosciences 42 running
- 4 New Actions BMBS covers all fields and areas of medicine and
biomedical sciences as practiced in Europe from basic and
preclinical to cliical research developed to translate the bench to
bedside concept.
Slide 17
Biomedicine and Molecular Biosciences BMBS 17 Molecular
Biosciences: Basic and applied biomolecular research; All areas of
genomics, proteomics and metabolomics (structures and functions);
Study of the Central Nervous System and neuronal connections,
cognitive neuroscience; immune system, cell migration, cell
dysfunctions, cellular mechanisms of diseases Molecular
Biosciences: Basic and applied biomolecular research; All areas of
genomics, proteomics and metabolomics (structures and functions);
Study of the Central Nervous System and neuronal connections,
cognitive neuroscience; immune system, cell migration, cell
dysfunctions, cellular mechanisms of diseases Biomedicine and
Specific Technologies: advanced imaging and treatment techniques
(basic research, diagnosis, treatment procedures), medical devices
and new medicines, advanced medical research on biomaterials Micro-
and Nanomedicine (including nanotechnologies), biomedicine/
molecular bioscience and pharmacologyinterdisciplinary issues in
the fields such as bioinformatics, biomedical engineering, medical
physics and chemistry, mathematical models in medicine.
Slide 18
18 BM1401 Raman4clinics: Raman-based applications for clinical
diagnostics Network of researchers in 17 countries up to now Start
date: 9 December 2014 End date: 8 December 2018 Proposer: Professor
Jrgen POPP [email protected] Leibniz Institute of Photonic
Technology, DE
Slide 19
19 BM1401 Raman4clinics: Raman-based applications for clinical
diagnostics Therapeutic Drug Monitoring Diagnosis of Infectious
Diseases Identification of Circulating Tumor Cells Histopathology
Of Cells And Tissue Sections Fiber Optic Endoscopy
Slide 20
20 BM1402 Development of a European network for preclinical
testing of interventions in mouse models of age and age-related
diseases (MouseAGE) Network of researchers in 18 countries up to
now Start date: 1 December 2014 End date: 30 November 2018
Proposer: Prof Ilaria Belantuono [email protected]
University of Sheffield, UK
Slide 21
21 BM1403 Native Mass Spectrometry and Related Methods for
Structural Biology Network of researchers in 10 countries up to now
Start date: 26 November 2014 End date: 25 November 2018 Proposer:
Professor Frank SOBOTT [email protected] Center for
Proteomics, University of Antwerp, BE
Slide 22
22 BM1404 Mye-EUNITER: European Network of Investigators
Triggering Exploratory Research on Myeloid Regulatory Cells Network
of researchers in 15 countries up to now Start date: 27 November
2014 End date: 26 November 2018 Proposer: Professor Sven BRANDAU
[email protected] University Duisburg-Essen, DE
Slide 23
Are you already in contact with other researchers and you would
like to submit a COST Action proposal? 23
Slide 24
COST Open Call Next collection date: March 2015 Stay tuned for
COST updates: www.cost.eu/opencall www.cost.eu/opencall
Slide 25
OPTION 3 Become a COST EXPERT 25
Slide 26
Become a COST Expert! 26 As a COST Expert, you will have the
opportunity to: Contribute to the evaluation of COST Open Call
proposals; Participate in the assessment of Action results and
outcomes; Be invited to take part in the assessment of COST
strategic activities.. As a COST Expert, you will have the
opportunity to: Contribute to the evaluation of COST Open Call
proposals; Participate in the assessment of Action results and
outcomes; Be invited to take part in the assessment of COST
strategic activities.. New experts can express their interest via
the COST Expert online registration form
(www.cost.eu/experts)www.cost.eu/experts An updated Curriculum
Vitae with a list of publications is required to demonstrate
competence in specific areas of expertise. More on COST Experts:
www.cost.eu/participate/experts.
www.cost.eu/participate/experts
Slide 27
COST European Cooperation in Science and Technology Avenue
Louise 149 1050 Brussels, Belgium T: +32 (0)2 533 3800 F: +32 (0)2
533 3890 [email protected] www.cost.eu Get COST News by e-mail by
signing up at www.cost.eu/notification www.cost.eu/notification
www.linkedin.com/groups?gid=1699127 www.facebook.com/COST.Programme
twitter.com/COSToffice
